D
D-dimer and fibrin/fibrinogen degradation products
Also called: (FDP); Fibrin/Fibrinogen Breakdown Product (FBP)
Basics the nurse needs to know
Disseminated intravascular coagulation (DIC) screen
D-dimer and fibrin/fibrinogen degradation products are part of the panel of tests to assess for DIC. The additional tests in this group include Prothrombin Time (see p. 525), Activated Partial Thromboplastin Time (see p. 42), Platelet Count (see p. 499), and Fibrinogen (see p. 315). DIC is a common and often severe coagulation disorder commonly precipitated by sepsis, severe tissue injury, or some complications of pregnancy. When the anticoagulation and fibrinolytic systems are overwhelmed by the underlying disorder, DIC can result. In DIC, the patient develops systemic microvascular thrombi and, as platelets and natural anticoagulant factors are depleted, the patient begins to bleed.
Interfering factors
NURSING CARE
Nursing actions are similar to those used in other venipuncture procedures (see Chapter 2), with the following additional measures.
Posttest
Dexamethasone suppression test
How the test is done
A variety of dexamethasone procedures are possible. Low-dose dexamethasone testing may be carried out overnight or over 2 days. Overnight testing requires the oral administration of dexamethasone at night (10 pm to 11 pm). The next morning, a plasma cortisol level is determined. With the 2-day method, dexamethasone is given orally every 6 hours for 2 days. A 24-hour urine specimen is obtained before and after administration (see discussion of 17-Hydroxycorticosteriods, p. 389), and a plasma cortisol test is performed 6 hours after the last dose of dexamethasone.